Short description:
Motion-based Drug Design
Drug notes:
RLY-4008 Clin1 multiple cancers; RLY-2608 Clin1 multiple cancers; 3 programs Clin0 oncology, undisclosed
Long description:
Relay Therapeutics is identifying drugs to alter protein kinetics to treat patients with cancer and genetic diseases. Proteins are not stationary - they move, and how they move can inform function and disease. Using their Dynamo platform, Relay is visualizing protein motions in HD movies and pioneering Motion-based Drug Design. The platform combines both deep structural understanding and chemical biology insights with AI and physics-based simulations to harness protein dynamics. With this, Relay can then develop unique hypotheses for how best to modulate a protein’s behavior and identify potential novel allosteric binding sites for therapeutics. Relay’s pipeline includes several promising product candidates in early and preclinical stages.
Jobs:
Research Informatics Technical Business Partner Cambridge, MA|14 days ago
Senior Director / Vice President, Site Engagement ... Cambridge, MA|17 days ago
Director / Senior Director: Clinical Pharmacology Cambridge, MA|42 days ago
Clinical Project Manager Cambridge, MA|52 days ago
Associate Director / Director, Clinical Business O... Cambridge, MA |64 days ago
Associate Director, Quality Assurance (GCP) Cambridge, MA |65 days ago
Senior Medical Director Cambridge, MA|100+ days ago
Director, Regulatory Affairs Cambridge, MA |100+ days ago